News|Articles|September 2, 2004

Pharmaceutical Technology

  • Pharmaceutical Technology-09-02-2004
  • Volume 28
  • Issue 9

Promoting Quality in Drug Manufacturing

Author(s)Jill Wechsler

FDA is re-engineering the CMC review process for innovator and generic drugs and backing risk-based ICH quality standards.
External Link - article-122719.pdf

Articles in this issue

over 21 years ago

Excel file and formula for Determining Probability of Passing the USP Content Uniformity Test

over 21 years ago

In the Spotlight-September 2004

over 21 years ago

Automation in a Digital, Webbed, and Wireless Age

over 21 years ago

September 2004

over 21 years ago

Design of an Aseptic Process Simulation

over 21 years ago

Use of the Bergum Method and MS Excel to Determine the Probability of Passing the USP Content Uniformity Test

over 21 years ago

Characterization of the Performance of Bin Blenders-Part 3 of 3: Cohesive Powders

over 21 years ago

Early Development Still Driving CRO Performance

over 21 years ago

Particulate-Free Pallets

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content